Fortrea
Amy Hadley currently serves as Vice President and Head of Business and Strategy Operations at Fortrea, starting in June 2023. Prior experience includes serving as Vice President and Global Head of Business Operations at Labcorp Drug Development from June 2021 to June 2023, and holding a board member position at Hemophilia of North Carolina from July 2020 to June 2022, where Amy chaired the Strategic Planning Committee. At Covance, from July 2018 to June 2021, Amy was Executive Director, overseeing COVID-19 Global Clinical Development governance and business continuity processes. Her extensive background also includes roles at IQVIA, where responsibilities included leading clinical delivery transformation and risk-based monitoring initiatives, as well as various positions at PPD and Duke University Medical Center. Amy holds a Bachelor of Science in Sports Medicine Exercise Sports Science from Elon University, earned between 1997 and 2001.
This person is not in any teams
This person is not in any offices
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.